Aspira Women's Health Files 2024 10-K
Ticker: AWHL · Form: 10-K · Filed: 2025-03-27T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, diagnostics
TL;DR
Aspira Women's Health filed its 2024 10-K. Check financials.
AI Summary
Aspira Women's Health Inc. filed its 2024 10-K on March 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Vermillion, Inc. and Ciphergen Biosystems Inc., is involved in in vitro and in vivo diagnostic substances. The filing details its financial performance and business operations for the period.
Why It Matters
This filing provides a comprehensive overview of Aspira Women's Health's financial health and strategic direction for the past fiscal year, crucial for investors and stakeholders to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a company in the diagnostic substances sector, Aspira Women's Health faces risks related to regulatory approvals, market competition, and technological advancements.
Key Players & Entities
- Aspira Women's Health Inc. (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-27 (date) — Filing Date
- Vermillion, Inc. (company) — Former Company Name
- Ciphergen Biosystems Inc (company) — Former Company Name
- 330595156 (dollar_amount) — EIN
- DE (location) — State of Incorporation
- 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 (location) — Business Address
- AUSTIN (location) — City
- TX (location) — State
FAQ
What is Aspira Women's Health Inc.'s primary business activity?
Aspira Women's Health Inc. is involved in 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES' as indicated by its Standard Industrial Classification code.
When did Aspira Women's Health Inc. file its 10-K report for the fiscal year 2024?
The 10-K report for the fiscal year ending December 31, 2024, was filed on March 27, 2025.
What were some of the previous names of Aspira Women's Health Inc.?
The company was formerly known as VERMILLION, INC. and CIPHERGEN BIOSYSTEMS INC.
Where is Aspira Women's Health Inc. headquartered?
The company's business and mailing address is 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX 78738.
What is the SEC file number for Aspira Women's Health Inc.'s 10-K filing?
The SEC file number for this 10-K filing is 001-34810.
From the Filing
0001641172-25-000983.txt : 20250327 0001641172-25-000983.hdr.sgml : 20250327 20250327172834 ACCESSION NUMBER: 0001641172-25-000983 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 81 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250327 DATE AS OF CHANGE: 20250327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34810 FILM NUMBER: 25780653 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 10-K 1 form10-k.htm false FY 0000926617 P3Y http://fasb.org/us-gaap/2024#NonoperatingIncomeExpense http://fasb.org/us-gaap/2024#NonoperatingIncomeExpense P1Y P1Y 0000926617 2024-01-01 2024-12-31 0000926617 2024-06-30 0000926617 2025-03-25 0000926617 2024-12-31 0000926617 2023-12-31 0000926617 2023-01-01 2023-12-31 0000926617 us-gaap:ProductMember 2024-01-01 2024-12-31 0000926617 us-gaap:ProductMember 2023-01-01 2023-12-31 0000926617 AWH:GeneticsMember 2024-01-01 2024-12-31 0000926617 AWH:GeneticsMember 2023-01-01 2023-12-31 0000926617 us-gaap:CommonStockMember 2022-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000926617 us-gaap:RetainedEarningsMember 2022-12-31 0000926617 2022-12-31 0000926617 us-gaap:CommonStockMember 2023-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000926617 us-gaap:RetainedEarningsMember 2023-12-31 0000926617 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0000926617 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000926617 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-12-31 0000926617 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0000926617 us-gaap:CommonStockMember 2024-12-31 0000926617 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000926617 us-gaap:RetainedEarningsMember 2024-12-31 0000926617 AWH:AtTheMarketOfferingAgreementMember 2024-01-01 2024-12-31 0000926617 AWH:AtTheMarketOfferingAgreementMember 2023-01-01 2023-12-31 0000926617 AWH:EquityLineOfCreditAgreementMember 2024-01-01 2024-12-31 0000926617 AWH:EquityLineOfCreditAgreementMember 2023-01-01 2023-12-31 0000926617 AWH:TwoThousandTwentyThreeDirectOfferingMember 2024-01-01 2024-12-31 0000926617 AWH:TwoThousandTwentyThreeDirectOfferingMember 2023-01-01 2023-12-31 0000926617 AWH:TwoThousandTwentyFourDirectOfferingMember 2024-01-01 2024-12-31 0000926617 AWH:TwoThousandTwentyFourDirectOfferingMember 2023-01-01 2023-12-31 0000926617 AWH:WarrantInducementAgreementMember 2024-01-01 2024-12-31 0000926617 AWH:WarrantInducementAgreementMember 2023-01-01 2023-12-31 0000926617 AWH:SecuritiesPurchaseAgreementsMember 2024-01-01 2024-12-31 0000926617 AWH:SecuritiesPurchaseAgreementsMember 2023-01-01 2023-12-31 0000926617 AWH:TwoThousandTwentyFourAtTheMarketOfferingAgreementMember 2024-01-01 2024-12-31 0000926617 AWH:TwoThousandTwentyFourAtTheMarketOfferingAgreementMember 2023-01-01 2023-12-31 0000926617 AWH:PrivatePlacementOfferingMember 2024-01-01 2024-12-31 0000926617 AWH:PrivatePlacementOfferingMember 2023-01-01 2023-12-31 0000926617 2024-07-01 0000926617 2024-10-17 0000926617 us-gaap:SubsequentEventMember 2025-02-11 0000926617 srt:MaximumMember 2024-12-31 0000926617 srt:MinimumMember 2024-12-31